Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA plus HMG ovarian stimulation in women with diminished ovarian reserve
ChiCTR-OCH-14004176Phase 4Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of medroxyprogesterone acetate and human menopausal gonadotrophin in infertility and Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Incidence of LH surge and Incidence of advanced ovulation. Started Jan 2014; status: completed.
02
Drugs
medroxyprogesterone acetatehuman menopausal gonadotrophin
03
Conditions
infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on ChiCTR-OCH-14004176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004176.